Researchers discovered blood RNA biomarkers that could support earlier diagnosis of Alzheimer's disease, potentially reducing the need for invasive tests. They identified brain-specific markers in circulating blood nanoparticles, which may offer a minimally invasive approach for diagnosing the progressive neurodegenerative disease.
SourceThe Mount Sinai Hospital / Mount Sinai School of Medicine·JournalNature Communications·DateJun 22, 2026
Researchers have found that cats show comparable patterns of brain deterioration as they age, similar to humans. This study, part of the Translating Time project, aims to unlock new insights into human ageing and disease by comparing cat and human brain development.
SourceUniversity of Bath·JournalBiology Open·TypeData/statistical analysis·DateJun 22, 2026
Insilico and SK Biopharmaceuticals collaborate on AI-powered drug discovery for neuroimmune disorders, aiming to accelerate discovery timelines and advance next-generation therapies. The partnership could be worth up to $2.5 billion, with Insilico receiving upfront and milestone payments.
SAMSUNG T9 Portable SSD 2TB
SAMSUNG T9 Portable SSD 2TB transfers large imagery and model outputs quickly between field laptops, lab workstations, and secure archives.
Researchers used AI to identify hidden peptides called prionins in prion and prion-like proteins, which can kill bacteria and may hold the key to treating drug-resistant infections. The study suggests that these proteins, commonly associated with neurodegenerative diseases, contain molecular features linked to immune defense.
SourceUniversity of Pennsylvania School of Medicine·JournalNature Microbiology·DateJun 19, 2026
A new research project will study the effect of immune cell aging on Parkinson's disease risk and progression. The team aims to identify individuals at greater risk for Parkinson's disease and develop targeted treatments.
Researchers have identified an experimental molecule called OLE that can restore part of the brain's protective function against Alzheimer's disease. The compound helps microglia enclose and contain beta-amyloid plaques, reducing their size and toxicity.
SourceUniversidad Miguel Hernandez de Elche·JournalCell Death and Disease·TypeExperimental study·DateJun 17, 2026
CalDigit TS4 Thunderbolt 4 Dock
CalDigit TS4 Thunderbolt 4 Dock simplifies serious desks with 18 ports for high-speed storage, monitors, and instruments across Mac and PC setups.
Researchers at University of Michigan Health have implanted the first wireless brain-computer interface (BCI) to restore communication in a patient with motor neuron disease. The study, called Connect-One Early Feasibility Study, aims to assess the device's long-term safety and effectiveness in synthesizing text and speech.
SourceMichigan Medicine - University of Michigan·TypeExperimental study·DateJun 17, 2026
The University of Michigan has successfully implanted the first-in-human Paradromics wireless brain-computer interface, designed to restore communication for patients with difficulty speaking. The clinical trial will focus on the device's long-term safety and assess its ability to restore communication through synthesized text and speech.
SourceMichigan Medicine - University of Michigan·TypeExperimental study·DateJun 17, 2026
A new study revealed that retinal photographs can accurately predict many common risk factors associated with developing Alzheimer's disease. The AI model identified regions of the retina linked to Alzheimer's risk factors, such as arteries and optical nerve, and predicted lifestyle factors like smoking and alcohol use.
SourceUniversity of Florida·JournalJournal of Alzheimer’s Disease·TypeComputational simulation/modeling·DateJun 16, 2026
Researchers developed LiON, a fluorescent reporter that visualizes biologically active iron and oxygen inside living cells. The tool revealed striking differences in iron and oxygen distribution across organs and cells, offering new opportunities to study diseases like cancer, liver disorders, and neurodegenerative conditions.
SourceInstitute of Science Tokyo·JournalCell Reports Methods·TypeExperimental study·DateJun 16, 2026
Aranet4 Home CO2 Monitor
Aranet4 Home CO2 Monitor tracks ventilation quality in labs, classrooms, and conference rooms with long battery life and clear e-ink readouts.
Researchers found that patients with Medicare Advantage insurance were more likely to receive certain types of stroke-preventing care and recover faster from strokes. In contrast, patients on traditional Medicare received more intensive post-stroke care and rehabilitation.
A new study found that intranasal davunetide reaches the brain in higher amounts in female mice when estrogen peaks, with similar results seen in healthy adults. The findings suggest earlier trials mixing males and females may have obscured the true effects of the drug.
SourceGenomic Press·JournalGenomic Psychiatry·TypeExperimental study·DateJun 16, 2026
A new study investigates whether obesity contributes to faster brain aging and earlier memory decline. Researchers found that high K63 polyubiquitination levels in young obese rats matched those seen in older brains, suggesting a connection between obesity-induced and age-related memory loss.
Researchers at Indiana University are using artificial intelligence and machine learning to discover new treatments for Alzheimer's disease. The team hopes to create AI-driven tools that can efficiently screen billions of compounds and prioritize those most likely to interact with disease-related targets.
Researchers at Nagoya University developed an AI tool, DiSPAH, to estimate ALS disease progression speed and identify muscle decline patterns. The study found six distinct patterns of disease progression among patients, with some experiencing rapid deterioration while others declined slowly.
SourceNagoya University·Journalnpj Digital Medicine·TypeComputational simulation/modeling·DateJun 14, 2026
Rigol DP832 Triple-Output Bench Power Supply
Rigol DP832 Triple-Output Bench Power Supply powers sensors, microcontrollers, and test circuits with programmable rails and stable outputs.
Researchers found a copper-based compound significantly reduces toxic Alzheimer's proteins and improves long-term spatial memory in laboratory experiments. The treatment repairs the brain's waste-clearing pump, allowing it to clear out trapped toxic proteins and reduce amyloid buildup by 42%.
SourceMonash University·JournalACS Chemical Neuroscience·TypeExperimental study·DateJun 14, 2026
Researchers from the University of Calgary and international collaborators explored the zoonotic potential of CWD in controlled laboratory settings. The study found that infectious prions can still be present and transmissible even without obvious clinical signs, highlighting the need for continued surveillance and research.
SourceUniversity of Calgary·JournalScience Advances·TypeExperimental study·DateJun 11, 2026
Researchers from Florida Atlantic University have identified a key immune pathway that appears to drive damaging inflammation in Huntington disease. Blocking this pathway reduced brain inflammation, protected neurons, and improved movement in a humanized mouse model of the disease.
SourceFlorida Atlantic University·JournalProceedings of the National Academy of Sciences·TypeExperimental study·DateJun 8, 2026
Apple iPhone 17 Pro
Apple iPhone 17 Pro delivers top performance and advanced cameras for field documentation, data collection, and secure research communications.
A large Japanese study found that maintaining a healthier profile with lower lifestyle and health risks can significantly lower dementia risk in people with one or no APOE ε4 alleles. However, individuals carrying two APOE ε4 alleles may require different preventive or therapeutic approaches.
SourceKyushu University·TypeData/statistical analysis·DateJun 5, 2026
A new AI tool, AIDD, combines brain scans with machine learning to accurately diagnose two common forms of dementia. The tool showed near-perfect accuracy in identifying Alzheimer's disease and dementia with Lewy bodies, offering a promising future for clinicians.
SourceUniversity of Florida·JournalNeurology·DateJun 5, 2026
Researchers have identified an experimental molecule called OLE that helps restore microglia's protective function against Alzheimer's disease. The compound reduces beta-amyloid plaque size and toxicity, improving cognitive performance in memory tests.
SourceUniversidad Miguel Hernandez de Elche·JournalCell Death and Disease·TypeExperimental study·DateJun 2, 2026
AmScope B120C-5M Compound Microscope
AmScope B120C-5M Compound Microscope supports teaching labs and QA checks with LED illumination, mechanical stage, and included 5MP camera.
Andrew Yang's research has reshaped scientific understanding of the blood-brain barrier and its role in brain health and disease. His latest study reveals new potential treatment targets for neurological diseases, normal aging, and sleep.
A new brain imaging test can detect Alzheimer's disease pathology in twice as many people before symptoms appear. The test uses a new tau PET tracer that identifies more tau-positive cases than the current standard, leading to better decisions about who is on an Alzheimer's trajectory.
SourceUniversity of Pittsburgh·JournalThe Lancet·DateMay 28, 2026
Researchers found biomarkers for Alzheimer's disease that correlated with minor cognitive differences in midlife adults. These biomarkers, measuring tau and amyloid plaque, were associated with a greater chance of cognitive decline, particularly in processing speed and executive function.
SourceUniversity of California - San Francisco·JournalThe Lancet·DateMay 28, 2026
Researchers suggest targeting upstream metabolic nodes to regulate mTORC1 signaling and autophagy defects in neurodegenerative diseases. Acetyl-CoA production modulation and p300 acetylation activity regulation may also hold therapeutic promise.
SourceScience Exploration Press·TypeLiterature review·DateMay 28, 2026
Apple MacBook Pro 14-inch (M4 Pro)
Apple MacBook Pro 14-inch (M4 Pro) powers local ML workloads, large datasets, and multi-display analysis for field and lab teams.
A new approach combines MRI scans and AI tools to measure fluid flow in the brain, shedding light on the glymphatic system’s mechanics. The study reveals two main ways the system washes away particles, with one way moving faster than the other.
SourceUniversity of Rochester·JournalScience Advances·DateMay 27, 2026
Researchers found that impaired virtual reality path integration was closely tied to brain structure and biomarkers associated with neurodegeneration. This suggests that VR-based navigation errors may reveal hidden changes in the brain long before symptoms arise, making it a promising behavioral marker for preclinical Alzheimer's disease.
SourceFujita Health University·JournalAlzheimer s Research & Therapy·TypeObservational study·DateMay 27, 2026
Researchers developed a technique that uses RNA origami to analyze sections of RNA, allowing for accurate sizing of repeat expansions in genetic disorders. The method shows promise for fast and affordable testing in clinical settings.
SourceUniversity of Cambridge·JournalNature Communications·DateMay 21, 2026
Apple Watch Series 11 (GPS, 46mm)
Apple Watch Series 11 (GPS, 46mm) tracks health metrics and safety alerts during long observing sessions, fieldwork, and remote expeditions.
A new study found irisin reduces clinical symptoms and neuron loss in a mouse model of MS. Irisin also protects neurons from inflammation-driven neurodegeneration.
SourceMass General Brigham·JournalNature Metabolism·TypeObservational study·DateMay 21, 2026
A medical school team has been awarded a $6 million grant to develop gene-replacement preclinical models of Parkinson's disease. The goal is to better understand the disease and support early-stage therapeutic research by identifying critical pathogenic mechanisms.
SourceUniversity of Minnesota Medical School·DateMay 21, 2026
Researchers mapped HuD-bound mRNAs across embryonic and adult mouse brains, finding shared biological pathways. The study suggests that adult neurons use an embryonic
SourceGenomic Press·JournalGenomic Psychiatry·TypeLiterature review·DateMay 19, 2026
A recent study by Dr. Walaa Oweis and Prof. Eran Meshorer found that protein clumps in the brain may actually be protecting neurons from stress, acting as a vital quarantine system.
SourceThe Hebrew University of Jerusalem·JournalCell Death and Differentiation·TypeExperimental study·DateMay 18, 2026
Apple AirPods Pro (2nd Generation, USB-C)
Apple AirPods Pro (2nd Generation, USB-C) provide clear calls and strong noise reduction for interviews, conferences, and noisy field environments.
Researchers analyzed brain tissue from MSA patients and found that the immune cells known as microglia appear to be exhausted or dysfunctional in later stages of the disease. The study suggests that an overactive immune system may contribute to the development of MSA, providing a potential target for future treatment.
SourceUniversity of Copenhagen·JournalNature Communications·DateMay 18, 2026
A new statistical approach used in Alzheimer's disease trials may exaggerate the link between amyloid reduction and cognitive benefits of new drugs. Researchers found that combining large groups of patients can hide variability and make it appear as if reducing amyloid is more predictive of cognitive benefit than it actually is.
SourceBrown University·JournalJAMA Neurology·TypeData/statistical analysis·DateMay 18, 2026
A three-year research project aims to identify the molecular pathways linking exposure to pesticides and air pollution to Parkinson's disease development and progression. The study will analyze human stem cells, animal models, and genetic analyses to understand how environmental toxins trigger disease onset.
SourceUniversity of California - Los Angeles Health Sciences·DateMay 14, 2026
The Pittsburgh Institute for Neurodegenerative Diseases will investigate how environmental exposures cause neurodegeneration and develop methods to prevent or mitigate these exposures. The project aims to improve diagnostics and future therapies for Parkinson's disease, a condition characterized by heterogeneity across individuals.
Researchers identified GPNMB as a key molecule driving brain cell damage in Parkinson's disease. Blocking this protein with antibodies may help slow disease progression by interrupting the spread of toxic brain proteins.
SourceUniversity of Pennsylvania School of Medicine·JournalNeuron·DateMay 12, 2026
Kestrel 3000 Pocket Weather Meter
Kestrel 3000 Pocket Weather Meter measures wind, temperature, and humidity in real time for site assessments, aviation checks, and safety briefings.
A review from Florida Atlantic University links obesity to Alzheimer's disease through disruptions in metabolism, highlighting the importance of mitochondrial function and gut-brain axis balance. Early detection and whole-body prevention may become possible through monitoring metabolic health.
SourceFlorida Atlantic University·JournalCells·TypeSystematic review·DateMay 5, 2026
Scientists have discovered a protective brain pathway that preserves dopamine-producing neurons and reduces degeneration in female models with Parkinson's disease. The study suggests that strengthening this pathway could help slow the progression of the disease, offering new potential for treatment.
SourceTexas A&M University·JournalJNeurosci·DateMay 4, 2026
Researchers developed a new photonic material using lead iodide, enabling high-speed data transmission in the terahertz frequency range. The material confines light within submicrometer regions, paving the way for integrated photonic circuits that could replace or complement electronic circuits.
SourceFundação de Amparo à Pesquisa do Estado de São Paulo·JournalNature Communications·DateMay 4, 2026
Researchers studying RNA pollution's impact on aging brains seek to develop therapeutic strategies for neurodegenerative diseases like Alzheimer's. Sanford Burnham Prebys scientist Anne Bang will use advanced robotics to test thousands of compounds.
Nikon Monarch 5 8x42 Binoculars
Nikon Monarch 5 8x42 Binoculars deliver bright, sharp views for wildlife surveys, eclipse chases, and quick star-field scans at dark sites.
Researchers at Indiana University School of Medicine developed a new method to analyze brain energy network patterns, revealing insights into Alzheimer's disease progression. The study found that brain networks reorganize as the disease progresses, with memory and language functions showing increased metabolic demand in early stages.
SourceIndiana University·JournalAlzheimer s & Dementia·DateApr 28, 2026
A new review proposes a prevention-focused framework for understanding Parkinson's disease risk, highlighting the role of early-life vulnerability, environmental exposures, and resilience factors. The study suggests that susceptibility to PD may begin earlier in life through interactions between biology and environment.
SourceChinese Medical Journals Publishing House Co., Ltd.·JournalNeuroprotection·TypeLiterature review·DateApr 28, 2026
Researchers at UTHealth Houston have been awarded a three-year, $7.8 million grant to better understand how Parkinson’s disease occurs in the brain. The project aims to identify proteins and cellular pathways involved in brain damage, with the goal of developing novel strategies for intervention.
SourceUniversity of Texas Health Science Center at Houston·DateApr 28, 2026
A global research network, led by ASAP and MJFF, is expanding its efforts to map the biological blueprint of Parkinson's disease and develop a standardized toolkit of global research resources. This expansion aims to accelerate the development of personalized therapies by understanding the disease's inherent heterogeneity.
Researchers found three distinct trajectories of cognitive decline: stable, slow and fast decline. Biomarker data showed that participants who declined faster had higher P-tau217 levels and smaller hippocampi.
SourceKeck School of Medicine of USC·JournalAlzheimer’s & Dementia·TypeRandomized controlled/clinical trial·DateApr 27, 2026
Sky & Telescope Pocket Sky Atlas, 2nd Edition
Sky & Telescope Pocket Sky Atlas, 2nd Edition is a durable star atlas for planning sessions, identifying targets, and teaching celestial navigation.
The researchers will investigate novel therapies to protect the aging brain from neurodegenerative diseases by eliminating RNA pollution. They will map out signatures of RNA pollution across over 200 cell lines and patient biofluids to understand its effects.
FINGERS-7B integrates lifestyle, clinical, genomic, and proteomic data to discover multi-omic biomarkers for preclinical Alzheimer's. The model delivers 4× more accurate preclinical diagnosis and 130% better responder stratification than prior art.
SourcePicower Institute at MIT·TypeComputational simulation/modeling·DateApr 27, 2026
A randomized clinical trial examined the impact of Alzheimer's disease and related dementias (ADRD) screening in older adults on family members. The study found that primary care screenings did not worsen quality of life, depression, or anxiety over two years.
SourceIndiana University·JournalJAMA Internal Medicine·DateApr 27, 2026
Researchers will use DNA-encoded chemical libraries and artificial intelligence to screen hundreds of millions of potential drug compounds, identifying those most likely to succeed in treating Alzheimer's. The project aims to shorten the timeline for identifying new treatments, bringing them to patients faster and with greater precision.
A phase 1 clinical trial has started enrolling patients with symptoms of prion disease, evaluating the safety and tolerability of a small interfering RNA targeting the prion protein. The trial aims to slow disease progression and is supported by NeuroNEXT, a program of the National Institute of Neurological Disorders and Stroke.
Sony Alpha a7 IV (Body Only)
Sony Alpha a7 IV (Body Only) delivers reliable low-light performance and rugged build for astrophotography, lab documentation, and field expeditions.
A recent study has found that epigenetic clocks are associated with cognitive impairment and dementia, but only specific epigenetic markers related to smoking exposure are linked to neurodegenerative changes. The study suggests that measures of epigenetic age acceleration capture different aspects of biological aging.
SourceImpact Journals LLC·JournalAging-US·TypeNews article·DateApr 23, 2026
A new study found comprehensive evidence that weight-loss GLP-1 receptor agonists like semaglutide reduce amyloid-beta and tau buildup in the brain. Consistent reductions were seen in animal and cell studies, with liraglutide showing the most positive effects.
SourceAnglia Ruskin University·JournalMolecular and Cellular Neuroscience·TypeSystematic review·DateApr 23, 2026
A national study found that people with severe strokes have a five times higher odds of developing dementia. Stroke severity also affects thinking and memory after stroke, highlighting the need for close monitoring and treatment of dementia risk factors.
SourceMichigan Medicine - University of Michigan·JournalJAMA Network Open·TypeObservational study·DateApr 23, 2026
tACS modulates brain oscillations, induces synaptic plasticity, and regulates neurotransmitter release to alleviate symptoms of various neuropsychiatric conditions. Personalized approaches are essential for treatment efficacy.
SourceChinese Medical Journals Publishing House Co., Ltd.·JournalChinese Medical Journal·TypeLiterature review·DateApr 22, 2026
Garmin GPSMAP 67i with inReach
Garmin GPSMAP 67i with inReach provides rugged GNSS navigation, satellite messaging, and SOS for backcountry geology and climate field teams.
A study from the University of São Paulo reveals that neurodegenerative processes extend beyond the central nervous system, affecting various targets throughout the body. The researchers identified over 9,000 autoantibodies linked to immune status, neurological damage, and symptoms specific to each disease.
SourceFundação de Amparo à Pesquisa do Estado de São Paulo·JournaliScience·DateApr 22, 2026
Researchers discovered that small lesions in white matter can trigger a response in connected grey matter, leading to neuronal activity fall, microglia activation, and synapse loss. However, this response is part of the repair process, essential for brain regeneration.
SourceCambridge Stem Cell Institute·JournalNature·DateApr 22, 2026
A study at University at Buffalo found that L-arginine enhances protein droplet stability, preventing fibril conversion and preserving microtubule assembly. This naturally occurring small molecule may help guide therapies targeting fibril formation in Alzheimer's disease.
SourceUniversity at Buffalo·JournalNature Communications·TypeExperimental study·DateApr 22, 2026
Fluke 87V Industrial Digital Multimeter
Fluke 87V Industrial Digital Multimeter is a trusted meter for precise measurements during instrument integration, repairs, and field diagnostics.
Researchers discover cancer-driving genes in microglia of Alzheimer's patients, suggesting a link between blood cancers and the neurodegenerative disease. The findings could lead to new diagnostic tools and therapeutic options for Alzheimer's.
SourceBoston Children's Hospital·JournalCell·DateApr 21, 2026
Researchers from Johns Hopkins Medicine have developed mini brain-like structures grown in the lab that could be used to evaluate how patients with Alzheimer's disease respond to certain drugs. The study found that tiny particles secreted by these brain tissues may contain cellular information that could help scientists find new biomar...
SourceJohns Hopkins Medicine·JournalAlzheimer’s & Dementia·DateApr 20, 2026